This article is more than 5 years old. Information may no longer be current.

Ortho-tag Inc. appoints Ken Laing as chief executive officer

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Ortho-tag Inc. has announced the appointment of Ken Laing as chief execuive officer. According to a company press release, Laing will lead strategic initiatives to market the company’s smart orthopedic implants transcutaneous near field communication chips (TNFC) and biosensor technologies.

“Ortho-tag will provide cutting-edge technology advancements to the way surgeons monitor their patients, and will contribute to the future integration between smart implants and telemedicine,” Laing stated in the release.

According to the release, an orthotag provides a postoperative, non-invasive solution to obtaining patient information regarding medical implants and post-operative diagnostics in the surrounding joint and tissue environment. TNFC chips and biosensors that are embedded into implants provide information and accountability regarding medical devices. This includes manufacturing information about the implant, surgical and patient information.